We quantified the mRNA for APC as described in the Materials and Methods.
HDQ-P1 cells were treated with emetine (25μg/ml) for 10 hours. RNA was extracted and quantitative PCR carried out as described in the Materials and Methods.
H1299 cells were transfected with a siRNA targeting p53 or with a siRNA not targeting this protein and mRNA was extracted 2 days after transfection.
For each value, three independent experiments were performed in triplicate.
Expression plasmid construction
The wild-type p53 cDNA was amplified, with BamHI tails, from pGEX2T-p53 and inserted into pCMVNeoBam (kindly provided by Bert Vogelstein, Johns Hopkins Oncology Center, Baltimore). Directed mutagenesis was performed to create the Q192X, R213X, E298X and W53X nonsense mutations. For each mutant, we checked the entire p53 sequence.
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Transactivation assays
DLD-1 cells were cotransfected, by the calcium phosphate method, with pCMVp53 mutants (5 µg), p53BS-luc (10 µg) and pCMVLacZ (2.8 µg). We added G418 (200 µg/ml) the day after transfection; 48 h after transfection, protein extracts were prepared and enzymatic activities were measured.
H1299 cells were cotransfected, in the presence of the Jet Pei reagent (Ozyme), with pCMV p53 W53X, as described in the Materials and Methods.
siRNA transfections
HDQ-P1 cells were cultured for 24 h with or without G418 (200 µg/ml). They were then cotransfected, in the presence of JetPEI (Ozyme), with the siRNA, the p53BS-luc reporter plasmid and pCMV lacZ, which was used to normalize luciferase activity for transfection and extraction efficiency (0.75 µg of each plasmid and 1.3 µg of siRNA per well of a six-well plate). Transfected cells were immediately incubated in medium with or without G418 (200 µg/ml) supplementation. Three days after transfection, the cells were harvested by centrifugation at 1200 rpm for 5 min at 4°C and lysed by vortexing in 150 µl of cold luciferase assay buffer. Luciferase and beta-galactosidase activities were assayed as described in Materials and Methods.
H1299 cells were cotransfected, in the presence of the DharmaFECT Duo transfection reagent from Thermo Scientific, with the siRNA (1.3 µg per well), pCMV p53R213X (0.25 µg per well), p53BS-luc (0.4 µg per well) and PCMV lacZ (0.75 µg per well) and dispensed into sixwell plates. G418 (200 µg/ml) was added directly after transfection. Two days after transfection, the cells were harvested for protein extraction, as described above for HDQ-P1 cells.
For each cell line, at least four independent transfection experiments were performed.
Flow cytometry analysis
For each experiment, the percentage of cells expressing p53 was estimated as follows: cells were harvested and rinsed in 1x PBS supplemented with 1% BSA and incubated with 80% We assessed the transactivation capacity of the mutant p53 W53X cDNA, following the transient transfection of H1299 cells, using a reporter plasmid containing seven p53 binding sites upstream from the luciferase firefly gene (p53BS-luc). We measured p53-dependent luciferase activity after 24 hours in the presence or absence of G418 (50, 100 and 200 µg/ml) or gentamicin (800 µg/ml). Luciferase activity is expressed as a percentage of the activity obtained with the WT p53 cDNA. Mean values are presented together with the SEM (n= 3).
Supplementary statistical analysis
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